SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'FE1'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7W_A_MTXA301_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 10 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.23A | 1e7wA-2qhxA:45.3 | 1e7wA-2qhxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7W_B_MTXB301_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 9 / 11 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.21A | 1e7wB-2qhxA:44.6 | 1e7wB-2qhxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7W_B_MTXB301_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 11 | ARG A 17SER A 111PHE A 113PRO A 115LEU A 188TYR A 191LEU A 226HIS A 241 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.9A)FE1 A1301 (-4.2A) | 0.68A | 1e7wB-2qhxA:44.6 | 1e7wB-2qhxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7W_B_MTXB301_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 11 | SER A 111PHE A 113PRO A 115TYR A 191LEU A 229HIS A 241 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNoneNoneFE1 A1301 (-4.2A) | 1.28A | 1e7wB-2qhxA:44.6 | 1e7wB-2qhxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1E7W_B_MTXB301_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 11 | SER A 111PHE A 113PRO A 115TYR A 191TYR A 194LEU A 229 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNoneFE1 A1301 ( 4.5A)None | 0.95A | 1e7wB-2qhxA:44.6 | 1e7wB-2qhxA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_A_MTXA1278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 10 | ARG A 17SER A 111ASP A 181LEU A 188TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A) | 0.30A | 1mxfA-2qhxA:40.2 | 1mxfA-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_A_MTXA1278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 10 | ARG A 17SER A 111ASP A 181TYR A 194LEU A 226 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.66A | 1mxfA-2qhxA:40.2 | 1mxfA-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_B_MTXB2278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181LEU A 188TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A) | 0.28A | 1mxfB-2qhxA:40.4 | 1mxfB-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_B_MTXB2278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181TYR A 194LEU A 226 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.61A | 1mxfB-2qhxA:40.4 | 1mxfB-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_C_MTXC3278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181LEU A 188TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A) | 0.33A | 1mxfC-2qhxA:40.6 | 1mxfC-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_C_MTXC3278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181TYR A 194LEU A 226 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.65A | 1mxfC-2qhxA:40.6 | 1mxfC-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_D_MTXD4278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181LEU A 188TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A) | 0.29A | 1mxfD-2qhxA:40.6 | 1mxfD-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MXF_D_MTXD4278_1 (PTERIDINE REDUCTASE2) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111ASP A 181TYR A 194LEU A 226 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.63A | 1mxfD-2qhxA:40.6 | 1mxfD-2qhxA:43.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_A_MTXA351_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 9 / 12 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.46A | 1p33A-2qhxA:44.4 | 1p33A-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_B_MTXB352_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 9 / 12 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.43A | 1p33B-2qhxA:44.2 | 1p33B-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_C_MTXC353_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 9 / 12 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.46A | 1p33C-2qhxA:44.3 | 1p33C-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_C_MTXC353_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 12 | SER A 111PHE A 113LEU A 188TYR A 191TYR A 194LEU A 229 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)None | 0.89A | 1p33C-2qhxA:44.3 | 1p33C-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_D_MTXD354_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 9 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181LEU A 188TYR A 191TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)None | 0.41A | 1p33D-2qhxA:43.9 | 1p33D-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P33_D_MTXD354_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 191LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNoneFE1 A1301 ( 4.9A) | 1.01A | 1p33D-2qhxA:43.9 | 1p33D-2qhxA:71.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFM_A_TOPA1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 9 | PHE A 113ASP A 181LEU A 188TYR A 194LEU A 226LEU A 229HIS A 241TYR A 283 | FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)NoneFE1 A1301 (-4.2A)None | 0.40A | 2bfmA-2qhxA:45.82bfmD-2qhxA:44.9 | 2bfmA-2qhxA:87.802bfmD-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFM_A_TOPA1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 9 | PHE A 113LEU A 188TYR A 194LEU A 226HIS A 241 | FE1 A1301 (-3.4A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)FE1 A1301 (-4.2A) | 1.34A | 2bfmA-2qhxA:45.82bfmD-2qhxA:44.9 | 2bfmA-2qhxA:87.802bfmD-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFM_B_TOPB1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 9 | PHE A 113ASP A 181LEU A 188TYR A 191TYR A 194LEU A 226LEU A 229HIS A 241 | FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)NoneFE1 A1301 (-4.2A) | 0.42A | 2bfmB-2qhxA:45.72bfmC-2qhxA:44.7 | 2bfmB-2qhxA:87.802bfmC-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFM_B_TOPB1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 9 | PHE A 113LEU A 188TYR A 191TYR A 194LEU A 226HIS A 241 | FE1 A1301 (-3.4A)FE1 A1301 (-4.5A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)FE1 A1301 (-4.2A) | 1.34A | 2bfmB-2qhxA:45.72bfmC-2qhxA:44.7 | 2bfmB-2qhxA:87.802bfmC-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_A_H4BA1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 8 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.27A | 2bfpA-2qhxA:46.4 | 2bfpA-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_A_H4BA1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 4 / 8 | SER A 111PHE A 113TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.76A | 2bfpA-2qhxA:46.4 | 2bfpA-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_B_H4BB1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 8 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.34A | 2bfpB-2qhxA:46.4 | 2bfpB-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_B_H4BB1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 8 | SER A 111PHE A 113LEU A 188TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.80A | 2bfpB-2qhxA:46.4 | 2bfpB-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_C_H4BC1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 8 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.23A | 2bfpC-2qhxA:45.6 | 2bfpC-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2BFP_D_H4BD1290_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 8 / 8 | ARG A 17SER A 111PHE A 113ASP A 181LEU A 188TYR A 194LEU A 226LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 (-4.5A)FE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A)None | 0.26A | 2bfpD-2qhxA:45.6 | 2bfpD-2qhxA:87.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_A_MTXA1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 9 | ARG A 17SER A 111PHE A 113PRO A 115TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A) | 0.22A | 2c7vA-2qhxA:41.2 | 2c7vA-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_B_MTXB1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.45A | 2c7vB-2qhxA:41.3 | 2c7vB-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_B_MTXB1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 1.03A | 2c7vB-2qhxA:41.3 | 2c7vB-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_C_MTXC1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.46A | 2c7vC-2qhxA:41.3 | 2c7vC-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_C_MTXC1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 1.05A | 2c7vC-2qhxA:41.3 | 2c7vC-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2C7V_D_MTXD1272_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 10 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A) | 0.26A | 2c7vD-2qhxA:40.8 | 2c7vD-2qhxA:42.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_A_LYAA1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.49A | 2x9gA-2qhxA:41.0 | 2x9gA-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_A_LYAA1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 1.03A | 2x9gA-2qhxA:41.0 | 2x9gA-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_B_LYAB1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.45A | 2x9gB-2qhxA:41.0 | 2x9gB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_B_LYAB1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.98A | 2x9gB-2qhxA:41.0 | 2x9gB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_C_LYAC1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.43A | 2x9gC-2qhxA:41.2 | 2x9gC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_C_LYAC1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 0.99A | 2x9gC-2qhxA:41.2 | 2x9gC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_D_LYAD1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 12 | ARG A 17SER A 111PHE A 113PRO A 115ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneNAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.43A | 2x9gD-2qhxA:40.8 | 2x9gD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9G_D_LYAD1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | SER A 111PHE A 113PRO A 115TYR A 194LEU A 226 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)FE1 A1301 ( 4.9A) | 1.01A | 2x9gD-2qhxA:40.8 | 2x9gD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9V_A_TMQA1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 11 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.53A | 2x9vA-2qhxA:41.2 | 2x9vA-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9V_B_TMQB1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 9 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.44A | 2x9vB-2qhxA:41.7 | 2x9vB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9V_C_TMQC1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 10 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.29A | 2x9vC-2qhxA:41.4 | 2x9vC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2X9V_D_TMQD1270_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 9 | SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.35A | 2x9vD-2qhxA:41.3 | 2x9vD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BMC_A_FOLA270_0 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111PHE A 113PRO A 115TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A) | 0.31A | 3bmcA-2qhxA:40.7 | 3bmcA-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BMC_B_FOLB270_0 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 11 | ARG A 17SER A 111PHE A 113PRO A 115TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A) | 0.33A | 3bmcB-2qhxA:40.5 | 3bmcB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BMC_C_FOLC270_0 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 12 | ARG A 17SER A 111PHE A 113PRO A 115TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A)None | 0.63A | 3bmcC-2qhxA:40.5 | 3bmcC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BMC_D_FOLD270_0 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 12 | ARG A 17SER A 111PHE A 113PRO A 115TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NoneFE1 A1301 ( 4.5A) | 0.33A | 3bmcD-2qhxA:40.7 | 3bmcD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQ7_A_DX2A271_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 10 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.49A | 3jq7A-2qhxA:41.2 | 3jq7A-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQ7_B_DX2B271_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 8 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.42A | 3jq7B-2qhxA:41.2 | 3jq7B-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQ7_C_DX2C270_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 8 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.52A | 3jq7C-2qhxA:40.1 | 3jq7C-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQ7_D_DX2D270_1 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 6 / 9 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A)None | 0.48A | 3jq7D-2qhxA:41.2 | 3jq7D-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQA_A_DX4A270_0 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 6 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A) | 0.18A | 3jqaA-2qhxA:40.8 | 3jqaA-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQA_B_DX4B270_0 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 6 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A) | 0.16A | 3jqaB-2qhxA:40.7 | 3jqaB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQA_C_DX4C270_0 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 6 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A) | 0.19A | 3jqaC-2qhxA:40.6 | 3jqaC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JQA_D_DX4D270_0 (PTERIDINE REDUCTASE1) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 5 / 6 | ARG A 17SER A 111PHE A 113ASP A 181TYR A 194 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)FE1 A1301 ( 4.5A) | 0.21A | 3jqaD-2qhxA:40.8 | 3jqaD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JDC_A_6JPA302_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 10 | ARG A 17SER A 111PHE A 113ASP A 181MET A 183TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)NoneFE1 A1301 ( 4.5A)None | 0.56A | 5jdcA-2qhxA:40.85jdcD-2qhxA:40.9 | 5jdcA-2qhxA:49.095jdcD-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JDC_B_6JPB302_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 9 | ARG A 17SER A 111PHE A 113ASP A 181MET A 183TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)NoneFE1 A1301 ( 4.5A)None | 0.54A | 5jdcB-2qhxA:41.0 | 5jdcB-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JDC_C_6JPC302_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 10 | ARG A 17SER A 111PHE A 113ASP A 181MET A 183TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)NoneFE1 A1301 ( 4.5A)None | 0.57A | 5jdcB-2qhxA:41.05jdcC-2qhxA:39.6 | 5jdcB-2qhxA:49.095jdcC-2qhxA:49.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JDC_D_6JPD302_1 (PTERIDINE REDUCTASE) |
2qhx | PTERIDINE REDUCTASE1 (Leishmaniamajor) | 7 / 11 | ARG A 17SER A 111PHE A 113ASP A 181MET A 183TYR A 194LEU A 229 | NAP A1300 ( 3.7A)FE1 A1301 ( 2.8A)FE1 A1301 (-3.4A)NAP A1300 ( 3.6A)NoneFE1 A1301 ( 4.5A)None | 0.57A | 5jdcA-2qhxA:40.85jdcD-2qhxA:40.9 | 5jdcA-2qhxA:49.095jdcD-2qhxA:49.09 |